NLRP3 and colitis: Therefore, NLRP3-mediated IL-18 secretion promoted differentiation of intestinal epithelial cells, maintained intestinal epithelial integrity and reduced intestinal epithelial cell proliferation during colitis remission, protecting cells from malignant transformation (130).